Inventor
FISCHER WILFRIED
DE40 patents
⚠️ This page may combine multiple inventors who share the name “FISCHER WILFRIED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HEXAL AG
15 patentsUS6022852AFeb 8, 2000
Pharmaceutical composition containing cyclosporin A
HEXAL AG92 citations98
US6303141B1Oct 16, 2001
Transdermally administrable medicament with ACE inhibitors
HEXAL AG53 citations95
US6248758B1Jun 19, 2001
Pharmaceutical antacid
HEXAL AG108 citations94
US6696413B2Feb 24, 2004
Pharmaceutical preparation with cyclosporin A
HEXAL AG26 citations92
US5904930AMay 18, 1999
Transdermal system in the form of a patch comprising a tamoxifen derivative
HEXAL AG37 citations92
US5856359AJan 5, 1999
Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same
HEXAL AG47 citations91
US5738869AApr 14, 1998
Transdermal drug preparation
HEXAL AG54 citations91
US6267990B1Jul 31, 2001
Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
HEXAL AG35 citations89
US6623752B1Sep 23, 2003
Patch for transdermal application for pergolid
HEXAL AG24 citations87
US5874107AFeb 23, 1999
Sustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agent
HEXAL AG12 citations74
US6071964AJun 6, 2000
Diclofenac/gamma-cyclodextrin inclusion compounds
HEXAL AG9 citations72
US5972376AOct 26, 1999
Transdermal system of tacrine/selegilin-plaster
HEXAL AG15 citations72
US6165498ADec 26, 2000
Transdermal preparation containing a loratidine metabolite with antihistaminic activity
HEXAL AG3 citations61
US5910320AJun 8, 1999
Tablet or capsule having a content of stable ranitidine hydrochloride form 1
HEXAL AG0 citations52
US6395297B1May 28, 2002
Transdermal preparation contacting a loratidine metabolite with antihistaminic activity
HEXAL AG1 citations51
BBC BROWN BOVERI & CIE
9 patentsUS4184013AJan 15, 1980
Electrochemical storage cell
BBC BROWN BOVERI & CIE31 citations91
US4018969AApr 19, 1977
Electrochemical storage cell
BBC BROWN BOVERI & CIE45 citations89
US4405696ASep 20, 1983
Electrochemical storage cell
BBC BROWN BOVERI & CIE21 citations82
US4216275AAug 5, 1980
Electrochemical storage cell or battery
BBC BROWN BOVERI & CIE20 citations81
US4414297ANov 8, 1983
Shunt element
BBC BROWN BOVERI & CIE16 citations74
US4206272AJun 3, 1980
Electrochemical storage cell
BBC BROWN BOVERI & CIE11 citations73
US4127705ANov 28, 1978
Electrochemical storage cell
BBC BROWN BOVERI & CIE16 citations72
US4207386AJun 10, 1980
Electrochemical storage cell
BBC BROWN BOVERI & CIE6 citations62
US4029857AJun 14, 1977
Electrochemical storage cell or battery
BBC BROWN BOVERI & CIE1 citations51
NOVOSIS PHARMA AG
3 patentsUS6757560B1Jun 29, 2004
Transdermal delivery system (TDS) with electrode network
NOVOSIS PHARMA AG79 citations95
US7383083B2Jun 3, 2008
Transdermal delivery system (TDS) with electrode network
NOVOSIS PHARMA AG41 citations90
US6440453B1Aug 27, 2002
Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment
NOVOSIS PHARMA AG44 citations86
HEXAL PHARMA GMBH
3 patentsUS5830505ANov 3, 1998
Active ingredient patch
HEXAL PHARMA GMBH41 citations92
US5683711ANov 4, 1997
Active ingredient patch
HEXAL PHARMA GMBH25 citations92
US5665767ASep 9, 1997
Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same
HEXAL PHARMA GMBH17 citations81
SANOL ARZNEI SCHWARZ GMBH
2 patentsUS5043280AAug 27, 1991
Method and apparatus for the manufacture of a product having a substance embedded in a carrier
SANOL ARZNEI SCHWARZ GMBH152 citations98
US5472710ADec 5, 1995
Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
SANOL ARZNEI SCHWARZ GMBH83 citations95